TY - CHAP M1 - Book, Section TI - Abbreviations A1 - Knicely, Daphne H. A1 - Abdel-Rahman, Emaad M. A1 - Greenberg, Keiko I. Y1 - 2021 N1 - T2 - Handbook of Home Hemodialysis AB - Table Graphic Jump Location|Download (.pdf)|PrintAAMIAssociation for the Advancement of Medical InstrumentationACE inhibitorAngiotensin-converting enzyme inhibitorAlk PhosAlkaline phosphataseALTAlanine aminotransferaseANSIAmerican National Standards InstituteAppApplicationARBAngiotensin-receptor blockerASNAmerican Society of NephrologyAVArteriovenousAVFArteriovenous fistulaAVGArteriovenous graftBDIBeck Depression InventoryBUNBlood urea nitrogenBWBody weightCADCoronary artery diseaseCaSRsCalcium-sensing receptorsCfCConditions for CoverageCFUColony-forming unitsCHDConventional three times per week hemodialysis; thrice-weekly in-center hemodialysis; conventional hemodialysisCKDChronic kidney diseaseCLIMB studyCrit-Line Intradialytic Monitoring Benefit studyCMMICenters for Medicare and Medicaid InnovationCMSCenters for Medicare & Medicaid ServicesCONCertificate of NeedCPTCurrent procedural terminologyCTComputed tomographyCVCCentral venous catheterCVDCardiovascular diseaseDCCDialysate calcium concentrationDFCDialysis Facility CompareDOPPSDialysis Outcomes and Practice Patterns StudyDRIP studyDry Weight Reduction in Hypertensive Hemodialysis Patients studyEDWEstimated dry weightEEGElectroencephalogramEMSEmergency medical servicesEODEvery other dayESAErythropoietin-stimulating agentESKDEnd-stage kidney diseaseESRD PPSESRD Prospective Payment SystemESRD QIPESRD Quality Incentive ProgramEUEndotoxin unitsFDAFood and Drug AdministrationFGF-23Fibroblast growth factor-23FHN trialFrequent Hemodialysis Network trialFMLAFamily Medical Leave ActFREEDOMFollowing Rehabilitation, Economics, and Everyday-Dialysis Outcome MeasurementsGFRGlomerular filtration rateHCVHepatitis C virusHDHemodialysisHFHeart failureHHDHome hemodialysisHHSHealth and Human ServicesHIPAAHealth Insurance Portability and Accountability ActHIVHuman immunodeficiency virusHOMER-DHOME Rehabilitation Treatment-DialysisHPTHyperparathyroidismHr-QOLHealth-related quality of lifeHTNHypertensionICD-10-CMInternational Classification of Disease, 10th Edition, Clinical ModificationIDEInvestigational device exemptionIDHIntradialytic hypotensionIDTInterdisciplinary teamISOInternational Standards OrganizationKDIGOKidney Disease: Improving Global OutcomesKDOQIKidney Disease Outcomes Quality InitiativeKDQOL-36Kidney disease quality of life 36-item short form surveyKEEPKidney Early Evaluation ProgramLVEFLeft ventricular ejection fractionLVHLeft ventricular hypertrophyLVMLeft ventricular massMACMedicare Administrative ContractorMAPMean arterial pressureMBDMineral bone disorder/diseaseMCPMonthly capitated paymentMIPPAMedicare Improvements for Patients and Providers ActNHANESNational Health and Nutrition Examination SurveyNHDNocturnal hemodialysisOSAObstructive sleep apneaPAKPurification packPCPPrimary care providersPDPeritoneal dialysisPETPositron emission tomographyPPPYPer person per yearPTFEPolytetrafluoroethylenePTHParathyroid hormoneQAQuality assuranceQAIQuality assurance and improvementQAPIQuality assurance and process improvementQOLQuality of lifeROReverse osmosisRPMRemote patient monitoringRRFResidual renal functionRRTRenal replacement therapyRVUsRelative value unitsSCDSudden cardiac deathSDHDShort daily hemodialysisSF-36Short form questionnaire-36 itemsp Kt/VSingle-pool Kt/V; non-equilibrated Kt/Vstd Kt/VStandard Kt/V; weekly standard Kt/VTCUTransitional care unitTDCTunneled dialysis catheterTVCTotal viable countUFUltrafiltrationURRUrea reduction ratioUSRDSUnited States Renal Data SystemVDRsVitamin D receptors SN - PB - McGraw Hill CY - New York, NY Y2 - 2024/03/29 UR - accessmedicine.mhmedical.com/content.aspx?aid=1178969216 ER -